161
7/21/2019 Klu Interna & Farmakologi http://slidepdf.com/reader/full/klu-interna-farmakologi 1/161 UKDI 2015  PRAJOGO WIBOWO

Klu Interna & Farmakologi

Embed Size (px)

DESCRIPTION

lansia

Citation preview

Page 1: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 1/161

UKDI

2015 

PRAJOGO WIBOWO

Page 2: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 2/161

Anti Hipertensi

Page 3: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 3/161

Page 4: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 4/161

Page 5: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 5/161

JNC VII

Page 6: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 6/161

Page 7: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 7/161

 AC)*I + ARB

Page 8: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 8/161

ACE-Inhibitor +

Diuretik

•,arget BP- . /012342 mm5g

 . /062372 mm5g i& 89 or

rena di!ea!e :;<

 . /0=>3?> i& protein%ria @

0g3=1h

• I& BP @=2302 mm5g above

target BP %!e t$o*dr%g

combination

• 5, ; 89

 . BP 062*064372*74-

i&e!tye modi&ication 6mo  dr%g

 . BP @012342- dr%g

o%rce!- ,he eventh Report o& the Joint Nationa Committee on

Prevention# 8etection# )va%ation# and ,reatment o& 5igh BoodPre!!%re( =226(  on!en!%! Pengendaian dan Pencegahan 8iabete! 9eit%!

,ipe = di Indone!ia( =22D(

Page 9: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 9/161

8i%reti"a antihiperten!i

• Bia!a dipa"ai thiazide . 5C, !inge do!e=>*>2 mg3hari !eama =*1 mingg%

:bia do!i! dinai""an !ebe%m 1 mingg%  

to"!i"<

• )&e" 5ipo"aemia :terapi !%pemen ;<#

dehidra!i# hiper%ri!emia :go%t<#

hipergi"emia# 8)

Page 10: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 10/161

CALCIU CHANNEL BLOC!ERS

• CCB men%r%n"an PR + BP

• 9e"ani!me "erEa pada hiperten!i :dan# pada

!ebagian# angina< - hambat in&%"! caci%m

"e daam !e otot poo! arteria• Pening"atan ri!i"o in&ar" mio"ard# rein&ar"!i

+ "ematian# ter%tama oeh !hort acting CCB

:Ni&edipine<

• Piihan A"lodipine

• Ni&edipine  ta"i"ardi

Page 11: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 11/161

β - BLOKER

• Pen%r%nan Cardiac O%tp%t

• 9etoproo + Atenoo- β1-cardioselective

• Beta'oo + bi#oprolol - F 0 *!eective boc"er! yang

metaboi!me primernya di hepar# tapi $aktu paruhn%a

la"a

• Nebivoo -F 0 *!eective boc"er dan va!odiator 

• Labetalol - p%nya ra!io 6-0 !ebagai antagoni! F- per

ora tanpa pengar%h 5R dan CO  indi"a!i hiperten!i

"arena pheo&hro"o&%to"a + h%perten#i'ee"er(en&ie#

• Car'edilol# antagoni! F dan :~ abetao<  indi"a!i

HT + heart )ailure

Page 12: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 12/161

Page 13: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 13/161

Obat 5, dengan Indi"a!i h%!%!

o%rce- ,he eventh Report o& the Joint Nationa Committee on Prevention# 8etection# )va%ation# and,reatment o& 5igh Bood Pre!!%re( =226(

Page 14: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 14/161

8r%g

combination! in

hyperten!ion-

recommendation!

Preferred

 ACEInhibitor/diuretic

 ARB/diuretic

 ACE-Inhibitor/CCB

 ARB/CCB

Acceptable

 Beta-blocker/diuretic

 CCB (dihydropyridine)/beta-blocker

 CCB/diuretic

 Renin inhibitor/diuretic

 Renin inhibitor/CCB

 Dihydopyridine CCB/non-dihydropyridine CCB

Unacceptable

 ACE-Inhibitor/ARB

 Renin inhibitor/ARB

 Renin inhibitor/ACE-Inhibitor

 RA inhibitor/beta-blocker

 CCB (non-dihydropyridine)/beta-blocker

 Centrally actin! a!ent/beta-blocker

Page 15: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 15/161

Page 16: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 16/161

Page 17: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 17/161

Page 18: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 18/161

Anti Angina

Page 19: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 19/161

Hn!tabe Angina

o%rce- )%ropean 5eart Jo%rna :)%ropean ociety o& Cardioogy<( =22D(

  iy ( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(

Page 20: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 20/161

Coronary 5eart 8i!ea!e

o%rce- Porth! )!!entia! o& Pathophy!ioogy Concept! o& Atered 5eath tate!

Page 21: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 21/161

 Ac%te Coronary yndrome!

o%rce!- ,*egment )evation 9yocardia In&arction( 5arri!on! Principe! o& Interna 9edicine( 0? th )d( =227(  iy ( Ac%te Coronary yndrome!( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(

Page 22: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 22/161

Page 23: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 23/161

Page 24: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 24/161

Loka#i #u"batan Lead Arteri !oroner  

In&erior II# III# aVK RCA

 Antero!epta V0*V= A8

 Anteroapi"a V6*V1 A8 :di!ta<

 Anteroatera V>*VD# I# aV CKL

Po!terior V0*V= :ta R $ave# notM $ave<

RCA

o%rce!- iy ( )ectrocardiogram( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(

Page 25: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 25/161

Nitrate

AN,I ANGINA

Page 26: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 26/161

AN,I ANGINA

I di" i

Page 27: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 27/161

Indi"a!i

Page 28: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 28/161

• ,erapi !pe!i&i" %nt%" mencegah in&ar" myocard dan

"ematian mengand%ng antiplatelet :a!pirin# A8P

receptor boc"er!< and lipid-lo$erin( a(ent##

"h%!%!nya !tatin

• Hnt%" terapi r%matan chronic !tabe angina# lon(-a&tin(

nitrate## &&b# ata% * blo&ker# bi!a dipiih dr%g o&

choice tergant%ng individ%a re!pon!e(

• Pada 5,# monotherapy dengan !o$reea!e ata% ong*

acting ccb or F boc"er! m%ng"in ade%ate(

• Pada normoten!i# ong*acting nitrate! m%ng"in coco"(

• ombina!i * blo&ker + &&b :eg# propranoo ;

ni&edipine< ata% = CCB berbeda :eg# ni&edipine and

verapami< ebih e&e"ti& 

Page 29: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 29/161

Page 30: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 30/161

Page 31: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 31/161

Pembl! dara!

) b i P 8V,

Page 32: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 32/161

)mboi Par% ec 8V,

• ,em%an "a!i" . ,a"i"ardia . ,anda= di!&%ng!i RV

• 8i!ten!i vena E%g%er • Left parasternal lift • = "omponen

p%mona mengera!• 9%rm%r !i!toi" yg

mening"at padain!pira!i

Page 33: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 33/161

Acute Limb Ischemia

• Pen%r%nan per&%!ie"!tremita! !ecaramendada" yang dapatmengancam viabiita! Earingan

• On!et , "in((u• DP  Pain# paor#

p%!ee!!ne!!#pare!the!ia# poi"iothermia#parai!i!

• Goden period- D Eam• 8'- arteriogra&i 8opper 

"orce# $nter-"ociet% &onsenss 'or t!e (anagement o' PA) * +A"& $$ ,idelines* .

Ch i Li b

Page 34: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 34/161

Chronic Limb

Ischemia

• In!%&i!ien!i arteriperi&er , "in((u

• !laudika#io

inter"itten . 8ipic% a"tivita! +

eeva!i t%ng"ai . 9etaboi!me

anaerob  a!ama"tat  muscle

cramping  . Nyeri ata%

b%rning padapantar pedi!

• 8'- ABI

"orce# 0asclar )isease o' +!e Etremities* Harrison2s Principle o' $nternal (edicine* 13t! ed* .

Tro"boan(iti# R1 in)la"a#i non-atero"ato#a .'a#o#pa#"e0 pada arteri 2

Page 35: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 35/161

(obliteran# .Buer(er/#di#ea#e0

. p 0 p'ena ke&il ulku# atau (an(ren di(iti

Laki-laki "uda3 perokok

8iabetic arteriopathy 9a"rova!"%er- CA8# PA8# CVA

9i"rova!"%er- retinopati# ne&ropati# ne%ropati# gangren

Giant ce arteriti! Va!"%iti! pada percabangan "rania ar"%! aorta# ter%tama a(,emporai! :tempora arteriti!Q< ; demam# &atig%e# BB t%r%n#anore"!ia

 Arteri*arteri $aEah

 "a%di"a!io mandib%a

Chronic imb i!chemia ,er%tama arteri e"!tremita! ba$ah !eteah "e%ar daripercabangan aortoiia"a :a( Iia"a# a( Kemorai!# a( ,ibiai!# a(8or!ai! pedi!<8'- ABI /2(4

 Arteriti! ,a"aya!%   Va!"%iti! gran%omato!a !i!temi"  aorta dan

percabangannya  a( %b"avia + a( Brachiocephaica

a%di"a!io e"!tremita!# p%!a!i a( Bra"hiai!# perbedaan,8 @02 mm5g antara "ed%a engan# br%it a( !%b"avia ata%aorta

Page 36: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 36/161

Penya"it Jant%ng Re%mati"

• e"%eae demamre%mati" a"%t yangtida" di*t' ade"%at

• 9ani&e!ta!i 02*62 th

pa!ca 8RA• Penya"it Eant%ng

"at%p . S- &%!i "omi!%ra

 fish mouth . AI ; 9 . AS ; AI ; 9

o%rce- Vav%ar 5eart 8i!ea!e( iy ( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(

  abatine 9( Poc"et 9edicine( 1th ed( =200(

Page 37: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 37/161

)ndo"arditi! In&e"ti& 

o%rce- e'ton 8J( 8iagno!tic Approach to In&ective )ndocarditi!( Avaiabe at-

Page 38: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 38/161

Penya"it Eant%ng re%mati" Penya"it Eant%ng "at%p :9# A# AI<# ri$ayatdemam re%mati" a"%t# t' tida" ade"%at

Peri"arditi! Nyeri dada taEam# menEaar "e m( ,rapezi%!# S dgre!pira!i# dg d%d%" "e depan#Pericardia &riction r%b ;3*( )&%!i peri"ardia ;3*

)G- , eeva!i di&%!# o$ MR bia e&%!iperi"ardia

9yo"arditi! T peri"arditi! ; S ,roponin,anda*tanda C5K

Page 39: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 39/161

Penya"it Jant%ng ongenita

Page 40: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 40/161

P8A

• P8A "eci- a!imptomati"• P8A be!ar- !imptomati"  

IS4B berulan(# takikardia3poor )eedin(3 #lo$ (ro$th  . S airan "e par%

 . %!ia = . 6 b%an !aat

tahanan va!"%er par%t%r%n

• Pira% dari "iri "e "anan be!ar beban vo%me V + A  diata!i A# V  e&t heart&ai%re

• Hiperten#i pul"onal  tahanan va!"%er par% tinggi

 penya"it va!"%er par%  reversed shunting #iano#i##iano#i# 

.#.#indro"a Ei#en"en(er0

BA5I 4REATUR• otot poo! va!"%er par% be%m

!emp%rna• tahanan va!"%er t%r%n ebih cepat

• gaga Eant%ng ebih a$a

o%rce- Congenita 5eart 8i!ea!e( Pathophy!ioogy o& 5eart 8i!ea!e( =22?(

Page 41: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 41/161

Patent 8%ct%! Arterio!%!

PDA kecil murmur kontinyu – machinery murmur

 pirau kiri - kanan saat fase sistolik dan diastolik 

PDA besar – PH 

pulsus celler S2 (P2) keras murmur kontinyu

 pirau masih kiri - kanan

fase sistolik dan diastolik  murmur sistolik 

 pirau kiri - kanan hanya

fase sistolik  tidak terdengar murmur murmur diastolik awal

 aliran melewati katup mitral

%b"avia !ini!tra

o%rce- Roebiono P( Penya"it Jant%ng Ba$aan- ect%re( =224(

Page 42: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 42/161

Ca%dicatio intermitten

• Intermittent ca%dication a"ibat dari ob!tr%"!iairan darah oeh atheroma! pada arteri !edang

dan be!ar 

• 4ento1i)%lline # a 'anthine derivative# i! tho%ght

to act by red%cing the vi!co!ity o& bood#ao$ing it to &o$ more ea!iy thro%gh partiay

ob!tr%cted area!(

• Cilo#ta6ol# a pho!phodie!tera!e type 6 :P8)6<

inhibitor# i! poory %nder!tood# b%t may have

!eective antipateet and va!odiating e&&ect!(

Page 43: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 43/161

HeArt 5ailre

Page 44: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 44/161

Gaga Jant%ng anan

• Cor p%monae- RV enargement ec

 primary lung disease  RV hypertrophy  RV &ai%re• )tioogy-

 . P%monary inter!titia di!ea!e- COP8#a!thma# inter!titia %ng di!ea!e

 . P%monary va!c%ar di!ea!e- p%monary5,# P)

 . 9echanica ventiation- "ipho!coio!i!#obe!ity# OA# ne%rom%!c%ar 

• ign! + !ymptom! . H%po1ia  tachycardia# cyano!i!# c%bbing . RH7  R7 li)t

 . S loud 4,3 ri(ht #ided S8 . R7 )ailure bac"$ard &ai%re

 S JVP# hepatomegay :to cardiaccirrho!i!<# a!cite!# peda edema

   tric%!pid reg%rgitation  RA diation  right !ided 1 gaop

  o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Page 45: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 45/161

Gaga Jant%ng anan

• )CG- RV5:RA8# R@ V0<#

tachyarrythmia

• Ro- RV5 :boot*

!haped# ape"!

terang"at<

De)ibrila#i

Page 46: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 46/161

De)ibrila#i

Page 47: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 47/161

o%rce- Jone! A( )CG Note!- Interpretation and 9anagement G%ide( =22>

Page 48: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 48/161

8r%g! &or 5eart Kai%re

9olon(an Sub 9olon(an Sediaan

Inotropi" Gi"o!ida Eant%ng Agoni! F*adrenergi"Inhibitor

&o!&odie!tera!e

8igitai!# 8igo"!in# 8igito"!in8ob%tamin Amrinon# 9irinon

8i%reti" oop di%reti",iazid

K%ro!emid5C,B%metanid

9etoazon

Va!odiator AC) inhibitor  Rea"!a!i otot poo!ang!%ng

Captopri# )naapri# Ko!inopri# M%inapriNa nitrop%!id# 5idraa!in# I!o!orbid9ino"!idi# Amodipin# Keodipin

Page 49: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 49/161

Indi"a!i

Gi"o!ida• Conge!tive heart &ai%re

• 8epre!i nod%! AV :pada ta"i"ardi

!%praventri"e paro"!i!ma<

Page 50: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 50/161

8igo"!inhati*hati pada GAGA GINJA

 do!i! dit%r%n"an

8igito"!in

 hati*hati pada GANGGHAN KHNGI5)PAR

Page 51: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 51/161

)RACHNAN 8IGI,AI

G)JAA• )"topi" ventri"e# di!ritmia ventri"e#

ta"i"ardi atria paro"!i!ma dengan

bo"# bo" Eant%ng deraEat = ata% 6:"ompet<

•  Anore"!ia# N3V# nyeri abdomen

• Per%bahan per!ep!i "%ning*hiEa%#ha%!ina!i vi!%a# p!i"o!i!

Page 52: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 52/161

Page 53: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 53/161

P)NGOBA,AN )RACHNAN 8IGI,AI• top gi"o!ida + di%reti"a yang "e%ar ;

• Ra$at ICH

•)G "ontiny%

• Beri &enitoin# ido"ain# pro"ainamid  %nt%"

ta"iaritmia

• Beri ai%m  bia AV bo"# "ontraindi"a!i

• Beri Ig antidigo"!in

• 5indari "ardiover!i ee"tri"

Page 54: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 54/161

Anti Aritmia

Ob t A ti it i

Page 55: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 55/161

Obat Antiarit"ia

9olon(an obat ekani#"e !er:a 2 &ontoh obat

ea! I Obat*obat yang men%r%n"an re!pon membran mea%i bo"ade"ana Na# di"eompo""an !e!%ai e&e"nya pada repoari!a!i- A(%inidin# pro"ainamid# di!opiramidB(ido"ain# &enitoin# to"ainidC()"ainid# &e"ainid

ea! II Obat*obat yang menghambat a"tivita! !impati" mea%i inhibitor Fadrenergi"- A(PropanooB(Obat F bo"er !eEeni!

ea! III Obat*obat yang memperpanEang poten!ia a"!i- A(AmiodaronB(Bretii%m

ea! IV Obat*obat yang menghambat airan ma!%" Ca yang ambat- A(Verapami

B(Obat bo"er "ana Ca

Page 56: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 56/161

Page 57: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 57/161

Page 58: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 58/161

Page 59: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 59/161

Page 60: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 60/161

Page 61: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 61/161

A ti it i i di k i

Page 62: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 62/161

Antiarit"ia %an( #erin( dipakai

9olon(an 4reparat

Inhibitor "ana Na %inidin# Pro"ainamid# 8i!opiramid# Aprindinido"ain# 9e"!iatin# Kenitoin# ,o"ainid

Inhibitor "ana Ca AmiodaronVerapami# 8itiazem

impatopegia Propanoo# Bretii%m

Indi"a!i

Page 63: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 63/161

Indi"a!i

%inidin•  Aritmia ventri"e + e"topi" ventri"e

• K%tter :Atria Kibria!i<  !ebe%mnya

diberi digitai! ata% β blo6er nt6!indari vagoliti6 pada nods A0

7 Kontra6si prematr atrial

Pro"ainamid :T "%inidin<

Page 64: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 64/161

8i!opiramid• ,a"i"ardi ventri"e

7 Kontra6si e6topi6 ventri6el

Page 65: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 65/161

ido"ain• 8i!ritmia ventri"e

Kenitoin

• 8i!ritmia ventri"e pada "erac%nan

digitai!

Page 66: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 66/161

Bretei%m•  Aritmia ventri"e di ICH

 Amiodaron

• 8i!ritmia atria + ventri"%ar yang

re!i!ten terhadap obat

Page 67: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 67/161

)iabetes

Page 68: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 68/161

In!%in

Page 69: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 69/161

In!%in

%mber- on!en!%! Pengendaian dan Pencegahan 8iabete! 9eit%! ,ipe = di Indone!ia( P)R)NI =22D(

Page 70: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 70/161

A8 +

Page 71: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 71/161

A8 +

55o%rce- Wo!dor& J(# et a(

IPA8 Cinica Practice

Con!en!%! G%ideine! =22D*=22?- 8iabetic "etoacido!i!(

9anaEemen 55

Page 72: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 72/161

9anaEemen 55

•Rehidra!i agre!i& • 0*6 N 2(4X = Eam

 . Ji"a Na;@0>2- ar%tan hipotoni" NaC2(1>X

•Pa!ca hemodinami" !tabi- menggantide&i!it cairan 7*02 daam 0*= hari . NaC 2(1>X a% 8>W

 . In&%!ion rate! o& =22.622 m3h o&hypotonic !o%tion

• In!%in :!hort acting< . Bo%! 02 IH ata% 2(0> IH3"gBB

 . 8rip 2(0 IH3"gBB3Eam

o%rce!- 8iabete! 9eit%!( 5arri!on! Principe! o& Interna 9edicine( 0? th )d( =227(

  Pet%nE%" Pra"ti! ,erapi In!%in pada Pa!ien 8iabete! 9eit%!( P)R)NI =22?(

Page 73: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 73/161

)islipidemia

5ipertrigi!eridemia

Page 74: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 74/161

5ipertrigi!eridemia

9anaEemen 8i!ipidemia-0( ,ent%"an !a!aran 8

=( 9odi&i"a!i gaya hid%p D mingg%

6( ,erapi &arma"oogi!0( 8

=( ,G

 Ei"a @ =22 pa!ca !a!aran 8 tercapai# 8 dosisstatin ata tamba!6an asam ni6otinat:;brat Hiper+, s*d* <=>. mg:dL# statin dptdigna6an

 Hiper+, <?.. mg:dL

 trn6an +,@

 ;brat6( 58

 I& i!oated o$ 58 in C58 e%ivaent- nicotinicacid# &ibrate

o%rce!- Pet%nE%" Pra"ti! Penataa"!anaan 8i!ipidemia( P)R)NI =221(

  Nationa Choe!tero )d%cation Program( Cinician! Poc"et Re&erence( =22?(

Page 75: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 75/161

o%rce!- Pet%nE%" Pra"ti! Penataa"!anaan 8i!ipidemia( P)R)NI =221(  Nationa Choe!tero )d%cation Program( Cinician! Poc"et Re&erence( =22?(

Page 76: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 76/161

5iper*8 ata% 5iper o*, aspan lema6 total lema6

Page 77: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 77/161

9anagement o& 8y!ipidemia in Ad%t!( Am Fam Physician( 0447

 Cen!

5iper*,G a!%pan "arbohidrat# a"oho# ema"

)&e" obat terhadap "adar ipid !er%m

Page 78: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 78/161

)&e" obat terhadap "adar ipid !er%m

:per"eni<

Obat !ol-LDL !ol-HDL T9

tatin  ?@-   ↑ >*0>X   ↓ ?*62X

Re!in  ?-><   ↑ 6*>X * 3 ↑

Kibrat   ↓ >*=>X   ↑ 02*=2X   ,<-<

 A!am ni"otinat   ↓>*=>X   ↑ 0>*6>X   ,<-<

Penghambatab!orb!i "oe!tero  

?-?@   ↑ 6*1X *

Statin# .H9-CoA Redu&ta#e Inhibitor#0

Page 79: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 79/161

Co""on eature#

• 8ecrea!e 8 + V8• It i! !tandard therapy to initiate

red%cta!e inhibitor therapy immediatey

a&ter myocardia in&arction# irre!pectiveo& ipid eve!

• Hepatotok#ik3 rhabdo"%ol%#i#

Page 80: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 80/161

Kib t

Page 81: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 81/161

Kibrate

• H%pertri(l%&eride"ia dimana V8predominan dan

dy!betaipoproteinemia(

Page 82: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 82/161

Page 83: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 83/161

 +!%roid Endocrinelain

Grave! 8i!ea!e

Page 84: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 84/161

Grave ! 8i!ea!e

•  A%toimm%ne  thyroid*!tim%ating Ig :TSI<#antithyrogob%in# ANA

• Ca%!e! D2*72X o&thyroto'ico!i!

• Kemae-mae T >*02-0#12*D2 y

• Cin( 9ani&e!ta!ion- . Di))u#e3 nontender

(oiter Th%roid bruit .+0 . Papitation# !$eating#

an'io%!ne!!# &atig%e#$ea"ne!!# $eight o!!#

diarrhea#oigomenorrhea

 . Ophtamoogy . Pretibia my'edema . P%mmer! nai

Ophtamoogy-

preorbita

edema#

conE%nctiva

inEection#

propto!i!

eparated

&ingernai! &rom

naibed

  o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Page 85: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 85/161

o%rce- ,hyroid Gand 8i!order!( 5arri!on! Principe! o& Interna 9edicine( 0?th )d( =227(

retini!me

Page 86: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 86/161

retini!me

• 5ipotiroidi!me "ongenita#bayi# ana"• )tioogi- de&i!ien!i iodine#• 9ani&e!ta!i "ini!-

 . Gangg%an pert%mb%hant%ang  !hort !tat%re#coar!e &acia &eat%re!#short stature

 . Gangg%an per"embanganP  retarda!i menta t(%( In %tero

 . Coar!e &acia &eat%re! . Protr%ding tong%e

o%rce!- Robbin! + Cotran! Pathoogic Ba!i! o& 8i!ea!e( ?th ed( =22>(

  Bate! G%ide to Cinica )'amination(

Page 87: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 87/161

8$ar&i!me 8$ar&i!me pit%itari- !hort !tat%re ec de&i!ien!i gro$th hormone8$ar&i!me ec a"ondropa!ia- !hort !tat%re ec gangg%anpemanEangan t%ang pada ca"ram epi&i!i!

Giganti!me 5iper!e"re!i gro$th hormone pada ana" :!ebe%m pen%t%panca"ram epi&i!i!<

 A"romegai 5iper!e"re!i gro$th hormone !eteah pen%t%pan ca"ram epi&i!i!9i"ro!e&ai H"%ran "epaa / *= 8

9i'edema 5ipotiroidi!me pada remaEa ata% de$a!a8itandai dengan meambatnya a"tivita! &i!i" dan menta# &atig%e#apati!# intoeran !%h% dingin# over$eight# !e!a" napa!# edema#broadening and coar!ening o& &acia &eat%re!# idah membe!ar#!%ara !era" dan daam :h%!"y voice<

Creatinine ina!e

Page 88: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 88/161

Creatinine ina!e

• I!oenzim C- . C!-B .:antun(# N /DX<  8 pada AMI9 miokarditis9

peri6arditis dgn mio6arditis9 r!abdomiolisis9 crushinjury 

D CK-MM (otot rangka9 F /?-1..G  S pada crushinjury # "eEang# hipertermia maigna# inEe"!i I9

 . C!-BB .otak# N T 2X<  S pada &edera otak :CVA#tra%ma<# hipertermia maigna# in&ar" "oon

o%rce- Gomea G# 5ai!t A( Cinician! Poc"et Re&erence( 00th ed( =22?(

Page 89: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 89/161

Kass Par

a!%! Gaga Pengobatan

Page 90: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 90/161

a!%! Gaga e goba a

Feni# !a#u# De)ini#i

!a#u# baru Pa!ien yang tida" pernah mendapat terapi ,B ata%pernah mendapat terapi /0 b%an

!a#u# ka"buh Pa!ien yang pernah dinyata"an !emb%h# timb% agi,B a"ti& 

!a#u# (a(al .smear positive failure0

• Pa!ien yang !p%t%m B,A tetap po!iti& !eteahmendapat OA,@ > b%an# ata%• Pa!ien yang menghenti"an pengobatannya !eteahmendapat OA, 0*> b%an dan !p%t%m B,A ma!ihpo!iti& 

!a#u# kronik Pa!ien yang !p%t%m B,A*nya tetap po!iti& !eteahmendapat pengobatan %ang :retreatment < eng"apyang di!%pervi!i bai"

DR-TB Re!i!ten!i terhadap ri&ampi!in dan IN5 ;3* OA, ain

%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(

ategori OA,

Page 91: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 91/161

g

%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(

5epatiti! Imba! Obat pada ,erapi ,B

Page 92: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 92/161

%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(

pirometri

Page 93: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 93/161

• PPO- K)V03KVC /?2X

• 8eraEat- K)V0

"orce# ,lobal "trateg% 'or t!e )iagnosis9 (anagement9 and Prevention o' &!ronic Obstrctive Plmonar)isease* ,OL) ..3*

Bron"ie"ta!i!

Page 94: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 94/161

• 8iata!i bron"hi abnorma +permanen   pooling materiap%r%en

• In&ama!i + de!tr%"!i !a%rannapa! %"( menengah  &ibro!i!#em&i!ema# bron"opne%monia#

ateeta"!i!• )tioogi-

 . In&e"!i- P. aeruginosa, H.influenza

 . Non*in&e"!i- ga! ammonia# a!pira!ia!am amb%ng

• 9ani&e!ta!i "ini!- bat%" p%r%enber%ang*per!i!ten# hemopti!i!

• PK- rhon"hi# $heezing• 8'- ro# CT .(old #tandard0

"orce# Bronc!iectasis* Harrison2s Principles o' $nternal (edicine* 13! ed* ..4*

Page 95: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 95/161

,B $ith m%tipe nod%e!

•9igratory bronchopne%monia•9%tipe nod%e!  hea $ith @@@ caci&ied gran%oma! :TB

granulomas are usually 1 or 2 in number•5i!topa!momaTtarget calcification!bull"s#eye calcification in center

o& nod%e :Pathognomonic<

III*learningradiolog%*com

 A!ido!i! Re!piratori"

Page 96: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 96/161

p

Di#order 4roble" Etiolo(% 4h%#i&al )indin(#

9etaboicacido!i!

Gain o& 5; oro!! o& 5CO6* 

8iarrhea# R,A# A8#actic acido!i!

%!!ma% re!piratory#dry m%co%! membrane#!peci&ic phy!ica &indingto it! ca%!e

9etaboica"ao!i!

Gain o& 5CO6* or o!! o& 5;

o!! o& ga!tric !ecretion:vomiting<# thiazide3oopdi%retic!

,etany# Chvo!te" !ign#!peci&ic phy!ica &indingto it! ca%!e

Re!piratoryacido!i!

5ypoventiation :CO= 

retention<

COP8# a!thma# CNdi!ea!e# OA

8y!pnea# an'iety#cyano!i!# !peci&ic

phy!ica &inding to it!ca%!e

Re!piratorya"ao!i!

5iperventiation :CO= o!!<#

high atit%de

5ypo'ia  tachypnea

pne%monia# p%m(

)dema# P)# re!trictive%ng di!ea!e

5yperventiation#cardiac rhythmdi!t%rbance

Page 97: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 97/161

Pen%a6it Hepar

I"ter%! Ob!tr%"ti& 

Page 98: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 98/161

oe!i!titi! A"%t et ca%!a oeithia!i!

Page 99: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 99/161

• )c ob!tr%"!i d%"t%! !i!ti"%!:bia!anya pada 5artmann! po%ch<

• 9ani&e!ta!i "ini!- . Nyeri per%t "%adran "anan ata!#

inten!ita! + d%ra!i @ epi!ode "oi"biier !ebe%mnya

 . 8emam# m%a# m%ntah . 9a!!a ; nyeri te"an "%adran "anan

ata! abdomen# ba$ah iga "anan . 8e&an! m%!"%er  . $urphy"s sign :) T D>X# P T 7?X<

• 8'- US9 hepatobilier  . oeithia!i!- !en!iti& + !pe!i&i"

 . oe!i!titi!- penebaan dinding @> mm#cairan peri"oe!i!ti"# 9%rphy!onogra&i"

HG- po!terior aco%!tic !hado$

+ 9%rphy HG

"orce# Biiary !y!tem( abi!ton! te'tboo" o& !%rgery- the bioogica ba!i! o& modern !%rgica practice( 07th ed( =22?(

  NEJM ..4J=>4#4.?

)n!e&aopati 5epati"

Page 100: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 100/161

p p

• egagaan hatimemetaboi!me N56 ;!%b!tan!i ain  edema!erebri ; &a!ene%rotran!mitter 

• Pemic%- S ammonia :inta"e#!ir"%a!i enterohepati"<

• Clinical dx   ∆MS +asterixis

7 +# protein9 la6tlosa9ri'aimin7 Pro;la6sis o# la6tlosa

ri'aimin

"orce# "abatine ("* Poc6et (edicine* ?t! ed* .11*

Pan"reatiti! A"%t ec oeithia!i!

Page 101: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 101/161

• )tioogi- bat% emped%:12X<#a"ohoi!me :62X<

• 9ani&e!ta!i- nyeriepiga!tri%m menEaar "ep%ngg%ng# ter%!*

mener%!# dg bng667 Lab#

D 8 amilase9 lipase . G S94T >1 "en%okon(

pankreatiti# e& (all#tone

 .  AP# biir%bin tida"!pe!i&i"

"orce# "abatine ("* Poc6et (edicine* ?t! ed* .11*

 Abses %epar

Page 102: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 102/161

p

• 9ani&e!ta!i "ini!

 .  Amoebia!i! inte!tina  ulku#ber(aun( .flask-shaped ulcer)  diare berdarah

 .  Amoebia!i! e"!trainte!tina  menemb%! dinding coon  !i!temi"

• A"oebi& li'er di#ea#e .ab#e# hepar0  

demam menetap# nyeri epiga!tri%m#diare

• 8'- . 8i!enteri amoeba- &e!e!  tro)o6oit

%an( "en(andun( RBC di &e!e!#PCR# %Ei antigen &e!e!

 .  Amoebic iver di!ea!e  US9##erolo(i3 "ikro#kopi #ediaana#pira#i

• ,'- . etronida6ole > 1 < "( -?< hari

o%rce!- Robbin! + Cotran! Pathoogic Ba!i! o& 8i!ea!e( ?th ed( =22>(

  %!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia(

5epatiti! A"%t

5 titi A

Page 103: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 103/161

5epatiti! A

• Keca*ora• No

chronicity . Ig9-

ac%tein&ection

 . IgG- pa!t

in&ection

5epatiti! B

Page 104: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 104/161

5epatiti! B• Bood# !e'%a#

perinata

• Inc%bation 0*D :=*6< mo

•  Ac%te in&ection- . < #ub&lini&al . 62X Ea%ndice . 0X &%minant

hepatiti!

• Chronicity . >X :ad%t*

ac%ired< . 42X :perinatay

ac%ired< . Cirrho!i!- =2*62X

o& chronic hep B

"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1

  Acte 0iral Hepatitis* Harrison2s Principle o' $nternal (edicine* 13t! ed* .

eroogi + Viroogi 5BV

Page 105: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 105/161

4etanda Interpreta#i

5B!Ag In&e"!i a"ti&3!edang berang!%ng( 9%nc% !ebe%m geEaa= m%nc%

5BeAg B%"ti repi"a!i vir%! dan in&e"tivita!

Ig9 anti*5Bc In&e"!i a"%tWindo$ period :5B!Ag :*<# anti*5B! not yet :;<

 Anti*5B! Re!o%!i penya"it a"ti& Petanda im%nita! :petanda t%ngga pa!ca im%ni!a!i<

IgG anti*5Bc In&e"!i 5BV ampa% :5B!Ag :*<< ata% "roni! :5B!Ag :;<<

IgG anti*5Be Repi"a!i vir%! //# in&e"tivita! //

5BV 8NA Repi"a!i a"ti& vir%! di hepar 

"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1

5epatiti! C

Page 106: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 106/161

5epatiti! C /.G

trans'sion9>.G $)

Little evidenceo' seal orperinataltransmission

$ncbation 1->M mo

Acte in'ection#  75%

subcinica  >G Candice

&!ronicit%  >.G  &irr!osis# .G

o' c!ronic"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1

  Acte 0iral Hepatitis* Harrison2s Principle o' $nternal (edicine* 13t! ed* .

Bari%m )nema . Ca oore"ta

Page 107: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 107/161

• IB8- S ri!i"o• GeEaa-

 . oon di!ta- per%bahan poade&e"a!i# ob!tr%"!i# "oi" abdomen#hematochezia

 . oon pro"!ima- anemia de&( Be!i#

nyeri dull # &e!e! cair • ,%mor mar"er- CA 04*4• creening-

 . Bari%m enema  Se <-< . oono!"opi  god !tandard %t"

!creening  e 42X

 . C, "oonogra&i

• 8'- Biop!i "oono!"opi

Bari%m enema double

contrast& "ar!inoma an%ar

"on!tri"ti&- apple core'

lesion

  o%rce!- ieberman 8A( creening &or coorecta cancer( N)J9 =2246D0-00?4(

$$$(earningradioogy(com

Page 108: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 108/161

Rea"!i 5iper!en!itivita!

T%pe4rotot%pe

I""une e&hani#"# 4atholo(i& Le#ion#

Page 109: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 109/161

T%pe%p

Di#order I""une e&hani#"# 4atholo(i& Le#ion#

,ipe I Immediate

 Anaphya'i!aergie! bronchiaa!thma :atopic&orm!<

Prod%ction o& Ig) antibody immediateNreea!e o& va!oactive amine! and othermediator! &rom ma!t ce! recr%itment o&in&ammatory ce! :ate*pha!e reaction<

Va!c%ar diation#edema# !mooth m%!cecontraction# m%c%!prod%ction# in&ammation

,ipeII

 Antibody*mediated

 A%toimm%nehemoytic anemiaGoodpa!t%re!yndrome

Prod%ction o& IgG# Ig9 bind! to antigenNon target ce or ti!!%e phagocyto!i! orNy!i! o& target ce by activatedcompement or Kc receptor! recr%itment

o& e%"ocyte!

Ce y!i! in&ammation

,ipeIII

Imm%necompe'mediated

y!temic %p%!erythemato!%!!ome &orm! o&gomer%onephriti!!er%m !ic"ne!! Arth%! reaction

8epo!ition o& antigen*antibody compe'e!compement activation recr%itment o&N N

e%"ocyte! by compement prod%ct! andKc receptor! reea!e o& enzyme! andNother to'ic moec%e!

Necrotizing va!c%iti!:&ibrinoid necro!i!<in&ammation

,ipeIV

Ce*mediated:deayed<

Contact dermatiti!m%tipe !cero!i!type I# diabete!tran!pantreEection

t%berc%o!i!

 Activated , ymphocyte! i< reea!e o&Ncyto"ine! and macrophage activation ii<, ce*mediated cytoto'icity

Periva!c%ar ce%arin&itrate! edema cede!tr%ction gran%oma&ormation

Page 110: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 110/161

8iagno!i! Banding Arthriti!

Page 111: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 111/161

OA RA 9out

Patoogi degenerati& Pann%! 8epo!i!i "ri!ta %rat:mi"rotophi<

On!et grad%a Grad%a A"%t

In&ama!i :*< :;< :;<

o"a!i Pangg%# %t%t#vertebra

9CP# PIP# $ri!t#an"e# "a"i

9,P# "a"i# an"e#

eteribatan !endi Poi Poi# !imetri! 9ono

,em%an "ha! Nod%! Bo%chard#5eberden

8evia!i %nar# !$annec"# bo%tonniere

ri!ta %rat

)"!traarti"%er * Nod% !%b"%tan#p%moner# "ardia"#!penomegai

,ophiBat% ginEaB%r!iti! oe"ranon

ab dbn RK :;<# anti*CCP :;< S a! ( Hrat

  o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Go%t

Page 112: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 112/161

Chronic Go%t

Page 113: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 113/161

7 (ani'estation# top!i9 nep!rolit!iasis9 brsitis9 c!ronictop!aceos got

&!ronic treatment#7 rate prodction MloI prine diet

7 M- de!%dration drgs Mt!ia"id9 oo# diuretic9#$ra"inamide7 &ro#!$axis  'reent attac6 I!en starting

anti!%perricemic t!erap% M"A$)9 colc!icine

7 Anti!$#eruricemic  goal A Q mg:dL

D $'# top!i M9 nep!rolit!iasis M9 or 'reent attac6 Mmin* attac6s9 ric acid </ mg:dL

D ant!ine oidase in!ibitor Mao#urinoD ricosric M#robenecidDo not start w/o prophylaxis & until 2-4 wk after acute attack 

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Go%t and Other Cry!ta Arthropathie!( 5arri!on! Principe! o& Interna 9edicine( 0?th ed( =227(

Rhe%matoid Arthriti!

Page 114: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 114/161

• ign!- &hroni&##%""etri& pol%arthriti#

• Pathoogy- In&ammatory#proi&erative !ynoviati!!%e :pann%!<

&ormation<# idiopathic#genetic

• 4ain3 #$ellin(3 "ornin(#ti))ne## ? h

• PIP# 9CP# $ri!t!# "nee!#an"e!# 9,P!# cervica!pine

• Joint de&ormitie!

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Page 115: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 115/161

o%rce- Aetaha et a( =202 Rhe%matoid arthriti! ca!!i&ication criteria( Arth (heum( =202

eptember?D-=>D4.70(

Page 116: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 116/161

Page 117: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 117/161

Page 118: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 118/161

Hematologi

 Anemia

Page 119: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 119/161

 Anemia Apa!ti"

Page 120: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 120/161

• Hipo#elularita# !%m!%m t%ang

• 4an#itopenia .  Anemia . e%"openia  in&e"!i ber%ang . ,rombo!itopenia  petechiae# p%rp%ra

• Bimoda pea"  remaEa + an!ia• )tioogi-

 . Idiopati" . 8e!tr%"!i !e p%nca- radia#i# ke"o# "imia

:benzen< . R' obat idio!in"rati"- klora")enikol#

NSAID# #ul)a# prep( )ma!# "arbamazepin . 7iru#- 55V*D# 5IV# )BV# parvo*B04#

po#thepatiti# .non A3 B3 C0

• 8'- . Pan!itopenia dg RI /=X . Biop!i !%m!%m t%ang

%m!%m hipoproi&erati&# diganti"an

oeh Earingan ema"

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

 Anemia 9egaoba!ti"

Page 121: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 121/161

ANEIA A!ROSITI!

•  nemia megalo!lastik   gangg%an !inte!i! 8NA . De)i#ien#i a#a" )olat

• 9an%tri!i :a"ohoi"# vegan<• Ggn metaboi!me &oat :pirimetamin#

trimetoprim<

7 8 demand M!amil9 dialisis . De)i#ien#i B?,  neuropati 

:peri&er# "o%mna aterai! +po!terior tra"t%! !pinothaami"%!#"orte"! !erebri<  baa# pare!te!i#!en!a!i po!i!i + vibra!i# demen!ia#ata"!ia

• 9an%tri!i :a"ohoi"# vegan<•  Anemia perni!io!a• Ga!tre"tomi #Crohn!# !pr%e

•  nemia non-megalo!lastik - iverdi!ea!e# a"ohoi!me

H"%ran eritro!it @ im&o!it# ova :ma"ro*

ovao!it<

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

9%tipe myeoma

Page 122: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 122/161

p y

• 9aignan!i !e B  Ab mono"ona Ig9• GeEaa-

 . Proi&era!i !e pa!ma di !%m!%m t%ang  ane"ia . Le#i litik tulan(  n%eri tulan(# )raktur ko"pre#i3

hiperCa,+

 . In)ek#i berulan( ec hipogammagob%inemia . 9in:al  protein light chain  to"!i" thd ginEa  gaga

ginEa# !indroma ne&roti"

• )e"tro&ore!i! 5b- Ben&e-Fone# protein :ight chain<

• 5ap%! darah tepi- ro%ea%'• Biop!i !%m!%m t%ang- pa!ma!ito!i! @02X

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

Page 123: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 123/161

9%tipe p%nch*o%t e!ion! O!teopenia

Kra"t%r "ompre!i

o%rce- $$$(earningradioogy(com

Page 124: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 124/161

ani)e#ta#i

Kra"t%r"ompre!i

O!teodi!tro&iginEa

Reten!i &o!&at  

hiper&o!&atemia  

hipo"a!emia  hiperP,5

!e"%nder 

O!teopenia * o!teoporo!i!

train %mba Nyeri ec regangan padaotot

Nyeri ber%bah dengan pergera"an

O!teomieiti! In&e"!i t%ang ,anda*tanda in&ama!i# demam# e!i iti"t%ang  o!teopenia# hiper"a!emia

o%rce!- ,he Pediatric Orthopaedic ociety o& North America(

=20=(

Idiopathic Thrombocytopenic Purpura *ITP

Page 125: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 125/161

• Tro"bo#itopenia /022#2223mm6• 02X I,P ; anemia hemoiti" a%toim%n  +van"s syndrome• )tioogi

 . Primer - d' e"!"%!i

 . e"%nder- vir%! :5IV# 5CV# 5BV# )BV<# %) Pylori # ANA .  Ana"- a"%t pa!ca in&e"!i . 8e$a!a- "roni"

• 9ani&e!ta!i "ini!- perdarahan m%"o"%tan# petechiae#p%rp%ra( Perdarahan !pontan bia ,r /=2#2223mm6

• Pemeri"!aan ab . B,# C, . 5ap%! darah tepi- "e(akario#it . Biop!i !%m!%m t%ang- 8 mega6ariosit

8iate!i! Perdarahan ain

Page 126: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 126/161

He"ol%ti& Ure"i&S%ndro"e

Thro"boti&Thro"bo&%topeni&

4urpura

8e&ini!i eainan o"%!i& va!"%erec agrega!i pateet

intrarena

eainan o"%!i& va!"%er ecagrega!i pateet !i!temi"

)tioogi higa to'in a"tivita! protea!e **@ vWKdi endote  agrega!i

pateet

)pidemioog

i

 Ana"# didah%%i diare

berdarah ec )5)C

8e$a!a

9ani&e!ta!iini!

,ria! 5H:trombo!itopenia ;anemia hemoiti"mi"roangiopati" ; gaga

ginEa

Pentad ,,P:trombo!itopenia ; anemiahemoiti" mi"roangiopati" ;Y 9 ; gaga ginEa ;

demam<

Page 127: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 127/161

4atolo(i ani)e#ta#i

 Anemiahemoiti"a%toim%n

 A%toim%n:Idiopati"# )# obat :!%&a#ri&ampi!in# %inidin# NAI8#d<<

 Anemia

 Anemiaapa!ti" 5ipoproi&era!i !%m!%m t%ang Pan!itopenia

im&oma 9aignan!i!e*!e im&oid di Earingan im&oid

im&adenopati#demam# "eringatmaam

e%"emia 9yeoproi&era!i e%"o!ito!i! ;bi!itopenia

Page 128: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 128/161

(alaria

9aariaBerat

Page 129: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 129/161

Berat

o%rce- G%ideine! &or the treatment o& maaria( =nd ed( W5O =20

,ataa"!ana 9aaria Berat

Page 130: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 130/161

Arte"i#inin I7=I•  Arte!%nat IV ata% I9 =(1 mg3"gBB :dibagi = do!i!<

pada 2# 0=# =1 Eam# !eanE%tnya 0(= mg3"gBB d !(d(pa!ien dapat min%m obat :hari 1*><

atau•  Artemeter I9 6(= mg3"gBB :dibagi = do!i!<#

!eanE%tnya 0(D mg3"gBB d !(d( Pa!ien dapatmin%m obat ora

ACT lan:utan .4O0

•  Artemi!inin ; amodia"%in 6 hari  atau• %inin ; tetra!i"in3do"!i!i"in3"indami!in ? hari

o%rce!- G%ideine! &or the treatment o& maaria( =nd ed( W5O =20

  9aaria Berat( %doyo AW# d""( B%"% AEar Im% Penya"it 8aam( )di!i IV( =22

Peny%it 9aaria

Page 131: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 131/161

Bla&k $ater)e'er   Ac%te intrava!c%ar hemoy!i! ca!!icay occ%ring a&terthe re*introd%ction o& %inine in ong*term re!ident! inPa!modi%m &acipar%m endemic area! and repeatedy%!ing the prod%ct( 0

CINICA PROKI)- ,he !ymptomatoogy appear!br%tay $ith emi!!ion o& porto*coored %rine# icter%!#

paor# na%!ea# &ever and ac%te rena &ai%re(0

Al(id alaria  A rare compication o& tropica maaria and it occ%r! in2(6?X o& ca!e!( Agid maaria i! characterized byhemodynamic di!order! a! !hoc" $ith prono%ncedmetaboic change! and hypothermia(=

 A !yndromic diagno!i! o& varying etioogy :dehydration#bacteria in&ection# beeding and3or adrena in!%&&iciency<(6

o%rce- 0< Br%nee K# et a( Bac" $ater &ever( Presse $ed) =22= ep ?60:=7<-06=4*61(

=< Popov AK( Agid maaria( $ed Parasito *$os,( =22> Jan*9ar:0<-02*=(

  6< acerda 9V( Agid maaria- a !yndromic diagno!i!( (ev -oc Bras $ed Trop( =224 Jan*

Keb1=:0<-?4*70(

9aaria tertiana :viva'<

Page 132: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 132/161

Page 133: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 133/161

Page 134: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 134/161

Page 135: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 135/161

PerEaanan Penya"it 9aaria

I#tilah De)ini#i

Page 136: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 136/161

I#tilah De)ini#i

erangan primer Periode m%ai dari a"hir ma!a in"%ba!i hingga m%ai

terEadi !erangan paro"!i!ma :tria! dingin# menggigi#demam + ber"eringat<

Periode aten Periode a!imptomati" tanpa para!itemia# antara d%a"eadaan paro"!i!ma

Re"%ren!i Ber%angnya para!itemia a!e"!%a !eteah pengobatan(8apat di!ebab"an oeh re"r%den!i# reap! :P( viva' dan P(ovae<# ata% in&e"!i bar%

Re"r%den!i Ber%angnya para!itemia a!e"!%a :dengan in&e"!i yang!ama< pa!ca pengobatan( A"ibat "iren! para!itemia

in"ompit "arena pengobatan yang tida" ade"%at(

Reap!e3rech%te Ber%angnya para!itemia a!e"!%a pada maaria P( viva'dan P( ovae yang dorman :hipnozoit< di hati(8apat terEadi daam interva mingg%*b%an(

o%rce!- G%ideine! &or the treatment o& maaria( =nd ed( W5O =202(

Page 137: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 137/161

 +i'oid

8emam ,i&oid

Page 138: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 138/161

6?2C122C

Co"pli&ation#

Da% -? Da% < Da% Da% ,?

In&ubationperiod

 A!ymtomatic

In'a#i'e pha#eIntermitent &ever 

5eadache

Kati%e

 Abdomina di!com&ort

Con!tipation

8iarrhoea

To1i& pha#eContin%o%! &ever 

Bradycardia

5epatomegay

penomegay

Con!tipation

8iarrhoea

Ro!e !pot

Con'ale#&en&eperiod

o%rce!- 5adinegoro R( Kever in Chidren- ect%re( K9HI(=202

Bood c%t%re

Keca c%t%re

Page 139: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 139/161

• 8' method!- c%t%re o& bood# !too# %rine# d%odena :bie< a!pirate# B9a!pirate !pecimen

• Bood c%t%re- main!tay &or d'  e 8 a'ter da%-3• God !tandard- B9 a!pirate• Wida-

 . Pening"atan @1' ipat !eteah 0 mingg% menega""an d' . HEi t%ngga dengan titer O 036=2 ata% 5 03D12 ; "ini! menyo"ong d'

o%rce!- Bac"gro%nd doc%ment-,he diagno!i!# treatment and prevention o& typhoid &ever( W5O =226(

  Pand%an Peayanan 9edi"( PAP8I =224(

Page 140: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 140/161

)enge

Page 141: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 141/161

 Amoebic Liver .isease

Page 142: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 142/161

• 9ani&e!ta!i "ini!

 .  Amoebia!i! inte!tina

 ulku#ber(aun( .flask-shaped ulcer)  diare berdarah

 .  Amoebia!i! e"!trainte!tina  menemb%! dinding coon  !i!temi"

• A"oebi& li'er di#ea#e .ab#e# hepar0  demam menetap# nyeri epiga!tri%m#diare

• 8'- . 8i!enteri amoeba- &e!e!  tro)o6oit

%an( "en(andun( RBC di &e!e!#PCR# %Ei antigen &e!e!

 .  Amoebic iver di!ea!e  HG##erolo(i3 "ikro#kopi #ediaana#pira#i

• ,'- . etronida6ole >1< "( -?< hari

Page 143: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 143/161

Page 144: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 144/161

Helmint!ologi

Page 145: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 145/161

Page 146: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 146/161

Page 147: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 147/161

-chistosoma 0aponicum

Page 148: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 148/161

• ,e%r- lateral kno!:tonEoan di !at% !i!i<

• 8e$a!a- betina!ea% menempe

pada Eantan pada

"anai! gine"opori!

• 5abitat- vena

me!enteri"a ie%!

%!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia( =22?

C8C( aboratory identi&ication o& para!ite! o& p%bic heath concern( Avaiabe

-chistosomiasis

Page 149: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 149/161

• ,ran!mi!i- ho!t !ip%t

 !er"aria penetra!i "%itman%!ia

• 9ani&e!ta!i "ini! .  A"%t- demam# &%*i"e

!yndrome

 . roni"- di!&%ng!i !a%rancerna + hepati"# nyeriabdomen# diare berdarah

• 8'- . 9i"ro!"opi- te%r 

 . eroogi

• ,'- pra6ikuantel 12*D2mg3"g !at% ata% d%a do!i!

%!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia( =22?

C8C( aboratory identi&ication o& para!ite! o& p%bic heath concern( Avaiabe

5IV3AI8

Page 150: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 150/161

• In&e"!i primer  .

Repi"a!i vir%! @@@ ; rapid activation ofC81  e'ha%!tion  C81 depetion .  A!imptomati"3!imptomati" . A&ute retro'iral #%ndro"e  6*D mg

pa!ca in&e"!i 0*= mg  monon%ceo!i!*i"e ine!!

• on!tit%!iona- demam# &%*i"e !y#li")adenopati (enerali#ata• Ne%roogi! :en!e&aiti!# meningiti!#

ne%ropati peri&er<• 8ermatoogi!- rua" "akulolapular

erite"ato#a# ulku# "ukokutan

 . Windo$ period - D*0= mingg% !ebe%m Ab :;<• Ka!e aten

 .  A!imptomati"# &)?• AIDSJ HI7 + CD8 ,<< atau  IO

Chronic idney .isease

Page 151: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 151/161

17( Ac%te idney InE%ry

Page 152: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 152/161

• G Cr Z>2X &romba!eine# or Sab!o%te by 2(>*0(2mg3d

• Oli(uria  . :HO /122 m3=1 h . /2(> m3"g D h<

Anuria :HO /022 m3=1h<

Page 153: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 153/161

Page 154: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 154/161

Nephrotic yndrome

Page 155: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 155/161

• Protein%ria @6(> g3=1 h• 5ypoab%minemia /6(2 g3

• )dema

• 5yperipidemia

• ipid%ria

• Compication- hypercoag%abe !tate#

in&ection# dr%g to'icitie! ec decrea!edprotein binding

Page 156: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 156/161

Page 157: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 157/161

 A!ido!i! a"tat

Page 158: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 158/161

Di#order 4roble" Etiolo(% 4h%#i&al )indin(#

9etaboicacido!i!

Gain o& 5; oro!! o& 5CO6* 

8iarrhea# R,A# A8#actic acido!i!

%!!ma% re!piratory#dry m%co%! membrane#!peci&ic phy!ica &indingto it! ca%!e

9etaboica"ao!i!

Gain o& 5CO6* or o!! o& 5;

o!! o& ga!tric !ecretion:vomiting<# thiazide3oopdi%retic!

,etany# Chvo!te" !ign#!peci&ic phy!ica &indingto it! ca%!e

Re!piratoryacido!i!

5ypoventiation:CO= retention<

COP8# a!thma# CNdi!ea!e# OA

8y!pnea# an'iety#cyano!i!# !peci&icphy!ica &inding to it!

ca%!e

Re!piratorya"ao!i!

5iperventiation:CO= o!!<# high

atit%de

5ypo'ia  tachypnea

pne%monia# p%m(

)dema# P)# re!trictive%ng di!ea!e

5yperventiation#cardiac rhythmdi!t%rbance

ri!i! ,iroid

Page 159: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 159/161

o%rce!- ,hyroid Gand 8i!order!( 5arri!on! Principe! o& Interna 9edicine( 0?th )d( =227(

5ipo"aemia

Page 160: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 160/161

• )tioogy- . ,ran!ce%ar !hi&ting- a"aemia#

in!%in . GI o!!- diarrhea# a'ative

ab%!e

 . Rena o!!- 8A# R,A# oopdi%retic!# hyperado!teroni!m

• Cin( 9ani&e!tation- na%!ea#vomiting# ileu## $eakne###"u#&le &ra"p# arr%th"ia#

•)CG- &attening o& , $ave . ,inver!ion# H $ave

o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(

H%perkale"ia Keakne##3 )la&&id paral%#i#3 nau#ea3 pare#the#ia3palpitation

Page 161: Klu Interna & Farmakologi

7/21/2019 Klu Interna & Farmakologi

http://slidepdf.com/reader/full/klu-interna-farmakologi 161/161

p pEC9J tall T

5yponatremia H!%a%y $ith Na /0=> m)3- na%!ea# vomiting#con&%!ion# ethargy# di!orientationevere :/0=2 m)3< or abr%pt- !eiz%re# coma# death

5ypernatremia Con&%!ion# irritabiity# ethargy# !t%por# coma# m%!cet$itching# !eiz%re

5ypocacemia 5yperactive deep tendon re&e'# carpopeda !pa!m#Chvo!te" !ign# !eiz%re# tetany# aryngo!pa!m)CG- proonged M, interva

5ypercacemia 5,# hypore&e'ia# S ("E&,# s!ortening o' T+ interval

5ypomagne!emia ,achycardia# tremor# m%!ce t$itching# hyperactive re&e'#tetany# !eiz%re